Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffsnews2023-12-06T16:22:48+00:00December 6th, 2023|Endpoints News|
Seagen positions Tukysa combo as option for breast cancer patients with brain metastasesnews2023-12-06T16:04:58+00:00December 6th, 2023|Endpoints News|
CatalYm’s efforts to revive obesity target for solid tumors yield positive PhIIa resultsnews2023-12-06T15:03:56+00:00December 6th, 2023|Endpoints News|
Aviv Regev leads Genentech’s next revolution with AInews2023-12-06T15:00:55+00:00December 6th, 2023|Endpoints News|
Pharvaris soars on mid-stage data for severe swelling condition, raises $300Mnews2023-12-06T14:35:14+00:00December 6th, 2023|Endpoints News|
FDA approves Novartis drug for rare blood disordernews2023-12-06T13:58:20+00:00December 6th, 2023|Endpoints News|
IGM Biosciences cuts 22% of workforce, axes hematologic oncology programnews2023-12-06T12:12:45+00:00December 6th, 2023|Endpoints News|
Merck KGaA’s evobrutinib disappoints in PhIII multiple sclerosis test, casting dark cloud over BTK classnews2023-12-06T12:06:13+00:00December 6th, 2023|Endpoints News|
Will the UK’s triple-pronged approach ease pricing, regulatory and financial bottlenecks?news2023-12-06T10:33:44+00:00December 6th, 2023|Endpoints News|
J&J notebook: Highlights from a day of pipeline and strategy discussionnews2023-12-06T09:11:56+00:00December 6th, 2023|Endpoints News|
